Artivion [AORT] vs QuidelOrtho [QDEL] Detailed Stock Comparison

Artivion

QuidelOrtho
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Artivion wins in 10 metrics, QuidelOrtho wins in 8 metrics, with 0 ties. Artivion appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Artivion | QuidelOrtho | Better |
---|---|---|---|
P/E Ratio (TTM) | -128.47 | -0.96 | Artivion |
Price-to-Book Ratio | 4.75 | 0.71 | QuidelOrtho |
Debt-to-Equity Ratio | 62.81 | 100.33 | Artivion |
PEG Ratio | 0.80 | -0.01 | QuidelOrtho |
EV/EBITDA | 48.19 | 7.96 | QuidelOrtho |
Profit Margin (TTM) | -4.43% | -17.01% | Artivion |
Operating Margin (TTM) | 9.72% | -0.73% | Artivion |
EBITDA Margin (TTM) | 9.72% | N/A | N/A |
Return on Equity | -5.02% | -15.64% | Artivion |
Return on Assets (TTM) | 1.70% | 1.36% | Artivion |
Free Cash Flow (TTM) | $11.05M | $-112.10M | Artivion |
1-Year Return | 53.48% | -27.05% | Artivion |
Price-to-Sales Ratio (TTM) | 4.93 | 0.73 | QuidelOrtho |
Enterprise Value | $2.19B | $4.61B | QuidelOrtho |
EV/Revenue Ratio | 5.42 | 1.68 | QuidelOrtho |
Gross Profit Margin (TTM) | 64.72% | 44.78% | Artivion |
Revenue per Share (TTM) | $10 | $41 | QuidelOrtho |
Earnings per Share (Diluted) | $-0.44 | $-6.97 | Artivion |
Beta (Stock Volatility) | 1.70 | 0.15 | QuidelOrtho |
Artivion vs QuidelOrtho Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Artivion | -1.26% | 0.40% | -7.14% | 31.57% | 62.04% | 44.55% |
QuidelOrtho | 2.18% | 20.31% | 13.03% | 5.80% | -7.80% | -29.11% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Artivion | 53.48% | 250.13% | 110.15% | 296.68% | 555.57% | 472.36% |
QuidelOrtho | -27.05% | -55.05% | -88.52% | 73.91% | 175.50% | 204.68% |
News Based Sentiment: Artivion vs QuidelOrtho
Artivion
News based Sentiment: MIXED
October was a mixed month for Artivion, with a significant earnings beat and positive analyst revisions offset by notable insider selling and fluctuating stock performance. The combination of positive financial results and concerning insider activity creates a complex investment narrative, making it a moderately important month for investors.
QuidelOrtho
News based Sentiment: MIXED
September presented a mixed bag for QuidelOrtho, with positive developments like the QUICKVUE launch and margin improvement initiatives offset by declining revenue and concerning financial health indicators. The company is actively working to adapt to a changing market, but significant uncertainties remain, making it a cautiously neutral investment.
Performance & Financial Health Analysis: Artivion vs QuidelOrtho
Metric | AORT | QDEL |
---|---|---|
Market Information | ||
Market Cap | $1.94B | $2.00B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 469,077 | 1,180,901 |
90 Day Avg. Volume | 440,382 | 1,194,930 |
Last Close | $40.59 | $31.93 |
52 Week Range | $21.97 - $45.07 | $22.05 - $49.45 |
% from 52W High | -9.94% | -35.43% |
All-Time High | $45.07 (Aug 22, 2025) | $306.72 (Aug 03, 2020) |
% from All-Time High | -9.94% | -89.59% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.15% | -0.04% |
Quarterly Earnings Growth | 0.15% | -0.04% |
Financial Health | ||
Profit Margin (TTM) | -0.04% | -0.17% |
Operating Margin (TTM) | 0.10% | -0.01% |
Return on Equity (TTM) | -0.05% | -0.16% |
Debt to Equity (MRQ) | 62.81 | 100.33 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $8.91 | $41.25 |
Cash per Share (MRQ) | $1.13 | $2.25 |
Operating Cash Flow (TTM) | $19.65M | $200.40M |
Levered Free Cash Flow (TTM) | $-12,697,875 | $410.48M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Artivion vs QuidelOrtho
Metric | AORT | QDEL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -128.47 | -0.96 |
Forward P/E | 176.31 | 11.06 |
PEG Ratio | 0.80 | -0.01 |
Price to Sales (TTM) | 4.93 | 0.73 |
Price to Book (MRQ) | 4.75 | 0.71 |
Market Capitalization | ||
Market Capitalization | $1.94B | $2.00B |
Enterprise Value | $2.19B | $4.61B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.42 | 1.68 |
Enterprise to EBITDA | 48.19 | 7.96 |
Risk & Other Metrics | ||
Beta | 1.70 | 0.15 |
Book Value per Share (MRQ) | $8.91 | $41.25 |
Financial Statements Comparison: Artivion vs QuidelOrtho
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | AORT | QDEL |
---|---|---|
Revenue/Sales | $112.97M | $692.80M |
Cost of Goods Sold | $39.86M | $349.50M |
Gross Profit | $73.11M | $343.30M |
Research & Development | $7.06M | $53.20M |
Operating Income (EBIT) | $8.38M | $48.70M |
EBITDA | $18.95M | $154.20M |
Pre-Tax Income | $3.48M | $-8.80M |
Income Tax | $2.14M | $3.90M |
Net Income (Profit) | $1.35M | $-12.70M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | AORT | QDEL |
---|---|---|
Cash & Equivalents | $37.69M | $127.10M |
Total Current Assets | $287.30M | $1.26B |
Total Current Liabilities | $51.94M | $1.05B |
Long-Term Debt | $356.98M | $2.27B |
Total Shareholders Equity | $294.25M | $3.00B |
Retained Earnings | $-61.77M | $123.10M |
Property, Plant & Equipment | $77.04M | $2.35B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | AORT | QDEL |
---|---|---|
Operating Cash Flow | $-17.94M | $41.90M |
Capital Expenditures | N/A | $-56.20M |
Free Cash Flow | $-20.59M | $9.40M |
Debt Repayment | $-66,000 | $-36.00M |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | AORT | QDEL |
---|---|---|
Shares Short | 1.08M | 8.15M |
Short Ratio | 2.52 | 7.03 |
Short % of Float | 0.03% | 0.20% |
Average Daily Volume (10 Day) | 469,077 | 1,180,901 |
Average Daily Volume (90 Day) | 440,382 | 1,194,930 |
Shares Outstanding | 41.95M | 67.26M |
Float Shares | 41.61M | 62.65M |
% Held by Insiders | 0.05% | 0.01% |
% Held by Institutions | 0.90% | 1.18% |
Dividend Analysis & Yield Comparison: Artivion vs QuidelOrtho
Metric | AORT | QDEL |
---|---|---|
Last 12-Month Dividend | $0.00 | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | $0.00 | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | $0.00 | N/A |
Ex-Dividend Date | N/A | N/A |